Terms: = Bone cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Prognosis
24 results:
1. [Prognostic analysis of children with Philadelphia chromosome-like acute lymphoblastic leukemia common genes].
Hu WD; Li B; Su SF; Liu YF; Liu W; Zhang WL; Zuo WL; Yu RH
Zhonghua Er Ke Za Zhi; 2023 May; 61(5):446-452. PubMed ID: 37096265
[No Abstract] [Full Text] [Related]
2. Targeting Podoplanin for the Treatment of Osteosarcoma.
Takemoto A; Takagi S; Ukaji T; Gyobu N; Kakino M; Takami M; Kobayashi A; Lebel M; Kawaguchi T; Sugawara M; Tsuji-Takayama K; Ichihara K; Funauchi Y; Ae K; Matsumoto S; Sugiura Y; Takeuchi K; Noda T; Katayama R; Fujita N
Clin Cancer Res; 2022 Jun; 28(12):2633-2645. PubMed ID: 35381070
[TBL] [Abstract] [Full Text] [Related]
3. Down-regulation of pdgfrβ suppresses invasion and migration in osteosarcoma cells by influencing epithelial-mesenchymal transition.
Xing S; Wang C; Tang H; Guo J; Liu X; Yi F; Liu G; Wu X
FEBS Open Bio; 2020 Sep; 10(9):1748-1757. PubMed ID: 32580247
[TBL] [Abstract] [Full Text] [Related]
4. The incidence, genetic characteristics, and prognosis of leukemia with concurrent pathogenic fusion genes: a series of 25 cases from a large cohort of leukemia patients.
Chen X; Wang F; Wang T; Zhang Y; Ma X; Yuan L; Teng W; Guo L; Liu M; Liu M; Chen J; Nie D; Zhang Y; Zhou X; Wang M; Chen KN; Zhu P; Liu H
Cancer Gene Ther; 2020 Feb; 27(1-2):89-97. PubMed ID: 31645680
[TBL] [Abstract] [Full Text] [Related]
5. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2019 Oct; 94(10):1149-1167. PubMed ID: 31423623
[TBL] [Abstract] [Full Text] [Related]
6. Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety.
Liao Z; Li F; Zhang C; Zhu L; Shi Y; Zhao G; Bai X; Hassan S; Liu X; Li T; Xing P; Zhao J; Zhang J; Xing R; Teng S; Yang Y; Chen K; Yang J
Exp Mol Med; 2019 Feb; 51(3):1-11. PubMed ID: 30816108
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical and laboratory characteristics of hematopathy with t(5;12)(q33;p13) translocation].
Wang S; Li L; Wang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):879-882. PubMed ID: 30512169
[TBL] [Abstract] [Full Text] [Related]
8. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of clinical factors and pdgfr-β in predicting prognosis of patients with clival chordoma.
Zhai Y; Bai J; Wang S; Gao H; Li M; Li C; Gui S; Zhang Y
J Neurosurg; 2018 Dec; 129(6):1429-1437. PubMed ID: 29303447
[TBL] [Abstract] [Full Text] [Related]
10. Increased expression of platelet derived growth factor receptor β on trephine biopsies correlates with advanced myeloma.
Bilalis A; Pouliou E; Roussou M; Papanikolaou A; Tassidou A; Economopoulos T; Terpos E
J BUON; 2017; 22(4):1032-1037. PubMed ID: 28952224
[TBL] [Abstract] [Full Text] [Related]
11. Differences in Dural Penetration of Clival Chordomas Are Associated with Different prognosis and Expression of Platelet-Derived Growth Factor Receptor-β.
Zhai Y; Bai J; Wang S; Du J; Wang J; Li C; Gui S; Zhang Y
World Neurosurg; 2017 Feb; 98():288-295. PubMed ID: 27506406
[TBL] [Abstract] [Full Text] [Related]
12. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
Czapiewski P; Kunc M; Haybaeck J
Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
[TBL] [Abstract] [Full Text] [Related]
13. bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.
Ramos F; Robledo C; Izquierdo-García FM; Suárez-Vilela D; Benito R; Fuertes M; Insunza A; Barragán E; Del Rey M; García-Ruiz de Morales JM; Tormo M; Salido E; Zamora L; Pedro C; Sánchez-Del-Real J; Díez-Campelo M; Del Cañizo C; Sanz GF; Hernández-Rivas JM;
Oncotarget; 2016 May; 7(21):30492-503. PubMed ID: 27127180
[TBL] [Abstract] [Full Text] [Related]
14. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract] [Full Text] [Related]
15. [The hematological malignancies related to primary hypereosinophilia and their diagnostics].
Skonieczka K; Matiakowska K; Haus O
Postepy Hig Med Dosw (Online); 2014 Dec; 68():1530-7. PubMed ID: 25834096
[TBL] [Abstract] [Full Text] [Related]
16. ABT-869 inhibits the proliferation of Ewing Sarcoma cells and suppresses platelet-derived growth factor receptor beta and c-KIT signaling pathways.
Ikeda AK; Judelson DR; Federman N; Glaser KB; Landaw EM; Denny CT; Sakamoto KM
Mol Cancer Ther; 2010 Mar; 9(3):653-60. PubMed ID: 20197394
[TBL] [Abstract] [Full Text] [Related]
17. Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients.
Ferraresi V; Nuzzo C; Zoccali C; Marandino F; Vidiri A; Salducca N; Zeuli M; Giannarelli D; Cognetti F; Biagini R
BMC Cancer; 2010 Jan; 10():22. PubMed ID: 20109225
[TBL] [Abstract] [Full Text] [Related]
18. Frequent deletion of CDKN2A and recurrent coamplification of KIT, pdgfrA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study.
Niini T; López-Guerrero JA; Ninomiya S; Guled M; Hattinger CM; Michelacci F; Böhling T; Llombart-Bosch A; Picci P; Serra M; Knuutila S
Genes Chromosomes Cancer; 2010 Feb; 49(2):132-43. PubMed ID: 19862822
[TBL] [Abstract] [Full Text] [Related]
19. Genetic aberrations of gastrointestinal stromal tumors.
Yang J; Du X; Lazar AJ; Pollock R; Hunt K; Chen K; Hao X; Trent J; Zhang W
Cancer; 2008 Oct; 113(7):1532-43. PubMed ID: 18671247
[TBL] [Abstract] [Full Text] [Related]
20. Imatinib: new indication. New indications, but not robust evidence.
Prescrire Int; 2008 Jun; 17(95):91-4. PubMed ID: 18623899
[TBL] [Abstract] [Full Text] [Related]
[Next]